Ascentage Pharma
Signal active
Investment Firm
Overview
Ascentage Pharma develops novel small-molecule therapies for cancer, hepatitis B, and age-related diseases. They have developed a pipeline of seven drug candidates that disrupt complex and difficult-to-target protein-protein interactions and are next-generation tyrosine kinase inhibitors.
Highlights
Founded
2009
Industry
Biotechnology
Employees
101-250
Investment
1
Lead Investment
0
Exits
undefined
Stages
Seed
Investor Type
N/A
Location
Asia
Contact Information
Social
Profile Resume
Ascentage Pharma, established in 2009 and headquartered in Asia., specializes in Seed investments across Biotechnology, Pharmaceutical, Biopharma. Their recent investments include Heluoxintu. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Investment portfolio
N/A
investments
1
Diversity investments
0
Lead investments
0
Number of exits
undefined
Investments
1
| Annouced Date | Organization Name | Industry | Money Raised |
|---|---|---|---|
| Jul 31, 2022 | Heluoxintu | Biotechnology | null |
Exits
0
Funding Timeline
Funding rounds
1
Investors
14
Funds
0
Funding Rounds
1
Ascentage Pharma has raised 1 rounds. Their latest funding was raised on Jul 31, 2022 from a Angel Round - Heluoxintu round.
| Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
|---|---|---|---|---|
| Jul 31, 2022 | Angel Round - Heluoxintu | - | 0 | - |
Investors
14
Ascentage Pharma is funded by 14 investor(s). Takeda and ArrowMark Partners Kantor are the most recent investors.
| Investor Name | Lead Investor | Funding Round | Money Raised |
|---|---|---|---|
Oriza Seed Capital (Oriza Yuandian) | No | Series C - Ascentage Pharma | 150.0M |
| - | No | Series C - Ascentage Pharma | 150.0M |
ArrowMark Partners | No | Series C - Ascentage Pharma | 150.0M |
Takeda | Yes | Post-IPO Equity - Ascentage Pharma | 75.0M |
TakedaFund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
| Annouced Date | Fund Name | Money Raised |
|---|---|---|
| May 10, 2013 | OTPPLESS | 1.0M |
| May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
Recent Activity
There is no recent news or activity for this profile.